2014-01-29 12:49:01 - Physician Views: Can the Launch of ViiV Healthcare's Dolutegravir Disrupt Gilead's Dominance in the HIV market? - a new market research report on companiesandmarkets.com
Reasons to Buy
To help gauge a more accurate view on how dolutegravir may shape the HIV market, this week´s Physician Views poll will ask US-based infectious disease specialists:
- How aware/informed they are about dolutegravir ahead of its pending PDUFA date
- How they expect the availability of dolutegravir to impact their usage of Gilead´s Stribild
- What percentage of dolutegravir usage they anticipate to occur in Isentress failure patients
- Whether combination use with Epzicom will have any negative impact on their prescribing of the drug
- What percentage of total patients they expect to be prescribing dolutegravir to in two year´s time
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.